Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Changes in MMP-9, MCP-1, and PAI-1 in the 3 Treatment Groups
Arithmetic mean ± SEM for the relative change from baseline to 12 weeks in matrix metalloproteinase-9 (MMP-9), macrophage chemoattractant protein-1 (MCP-1), and plasminogen activator inhibitor-1 (PAI-1) in the 3 treatment groups (solid bars = pioglitazone; open bars = simvastatin; hatched bars = pioglitazone plus simvastatin): *p < 0.05 versus baseline; **p < 0.01 versus baseline; ***p < 0.001 versus baseline.
|
